These aren't stages in a process — they're four methodological lenses we apply side by side, depending on what a question demands.
We lean on observational data, statistical evidence, and phenotypic patterns — empiric risk — to guide diagnoses, particularly for complex traits and non-Mendelian disorders, while staying honest about the limits of purely theoretical or single-gene models.
Our research team studies, predicts, and maps how genes behave and evolve within populations over generations — work aimed at the best possible healthcare approaches and precision medicine, not just description for its own sake.
Precision medicine at population scale needs a shift in tooling as much as in thinking. We use algorithms, statistical frameworks, and machine learning to analyse DNA, RNA, and epigenetic data — working toward predicting phenotype directly from genotype.
Our team is building toward large-scale analysis — from hypothesis to high-throughput sequencing, multi-omics, and AI — extracting patterns from massive biological datasets to enable precision medicine and predictive drug modelling.